Skip to main navigation Skip to search Skip to main content

Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study

  • Cihan Yurdaydin
  • , Heiner Wedemeyer
  • , Florin A. Caruntu
  • , Manuela G. Curescu
  • , Kendal Yalcin
  • , Ulus S. Akarca
  • , Selim Gurel
  • , Stefan Zeuzem
  • , Andreas Erhardt
  • , Stefan Lueth
  • , George V. Papatheodoridis
  • , Kerstin Port
  • , Onur Keskin
  • , Monica N. Radu
  • , Mustafa K. Celen
  • , Ramazan Idilman
  • , Judith Stift
  • , Ingmar Mederacke
  • , Benjamin Heidrich
  • , Michael P. Manns
  • Hans Peter Dienes

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)202A-203A
Number of pages2
JournalHepatology
Volume56
Publication statusPublished - Oct 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this